Merck Shares Plunge on Vioxx Denial News WHITEHOUSE STATION, NJ - Shares of Merck  amp; Co. plunged almost 9 percent Monday after a media report said that documents show the pharmaceutical giant hid or denied evidence for years that its blockbuster arthritis drug Vioxx cause heart problems.